HSIRI THERAPEUTICS

From the company

Hsiri Therapeutics is focused on discovering and developing therapies for infections due to drug resistant bacteria and drug resistant fungal diseases. Its research focuses on mycobacterial infections, resistant bacterial pathogens, and drug resistant fungal pathogens. Research concepts originated from the University of Notre Dame and Montana State University. Discovery and research laboratories are located in South Bend, IN, with corporate and development staff in Media, PA.